Corporate Headquarters
1900 Avenue of the Stars
Suite 310
Los Angeles, CA 90067
310.843.9300
Fax: 310.843.9304
Offices located nationwide,
please call for a location nearest you
|
America's
Homeland Security Enhanced by Paladin Capital's
$10,500,000 Investment In AgION Technologies'
War Against Bacteria
January 28, 2003
Washington , D.C. , Paladin Capital Group's
Homeland Security and Partners' Funds announced
today a $10.5 million investment in AgION
Technologies, Inc., the leading provider
of engineered antimicrobial solutions that
continuously prevent the growth of bacteria,
mold, and fungus on a broad range of industrial,
consumer and medical products. Michael
Steed, Paladin's Managing Director, created
Paladin's Homeland Security Fund by bringing
together former top military and intelligence
officials including the CIA's James Woolsey,
National Security Agency's Lt. General
Kenneth Minihan and Naval Warfare technical
advisor, Dr. Alf Andreassen, to develop
the Paladin Homeland Security Fund to invest
in existing companies with immediate solutions
designed to prevent and defend against
terrorist attacks as well as to cope and
recover from such attacks or other threats.
AgION will use this new funding to expand
sales and marketing while it continues
its development of cutting-edge product
applications. The Company's flagship product
is sold under the AgION trademark, and
when AgION™ is incorporated into
or applied to finished products, it will
continuously control the growth of microbes
in or on the product. In most cases its
use can be engineered to last for the lifetime
of the product. The technology also is
safe and efficacious. AgION antimicrobial
is registered with the EPA for numerous
applications including food and drinking
water contact as well as heating, ventilation
and air conditioning systems. It also is
recognized by the FDA as an acceptable
food contact substance.
Given the enormous range of applications
for the AgION antimicrobial, a diverse
number of global companies have capitalized
on AgION engineered solutions. These include:
Honeywell (humidifiers); DuPont (various
coatings for multiple applications); Vygon
(medical catheters); Bosch Siemens BSH
(refrigerators); Doctors' Research Group
(stethoscope diaphragms); Specialty Filaments
(janitorial and home brushes); Ice-O-Matic
(ice dispensers); Robitussin (humidifiers);
Teva Sandals (2001 Time magazine "Most
Innovative Product" winner); Colorcon
(medical, food and pharmaceutical packaging);
FossFibre (fiber for filters and bedding);
Sargent's SARGuard (architectural hardware
for commercial construction); Waterpik
(personal health care); and AK Steel (stainless
and carbon steel for multiple applications
- Popular Science "Best of What's
New 2001"). In addition, the AgION
antimicrobial is being featured in the
AK Steel Concept Home, an award-winning
antimicrobial home, now under construction
in the Los Angeles area (www.akconcepthome.com).
"This partnership with Paladin dramatically
increases our capability to market the
AgION antimicrobial throughout the world," explains
Roger M. Freedman, AgION's Chairman and
CEO. "This additional funding validates
our importance as a homeland security investment
and continues to strengthen our leadership
position worldwide."
Michael Steed, Paladin Capital Group's
Managing Director, adds: "AgION has
enormous potential to be the leader in
the fight against bacterial attacks initiated
by terrorists on unsuspecting civilian
and military personnel by becoming the
world's most innovative, cost-effective
supplier of antimicrobial compounds. Both
our principals and advisory board have
recognized this opportunity as well as
its enhancement of our funds' portfolios."
Paladin's Alf Andreassen, Ph.D., and Paul
Bracken, Ph.D., have joined the AgION Technologies'
board of directors. Dr. Andreassen, a principal
of Paladin's Homeland Security Fund, is
a former technical adviser for naval warfare
for the Office of the Chief of Naval Operations
as well as a former executive at AT&T
and Bell Laboratories, the latter where
he promoted technological innovation in
national security. Dr. Bracken, a member
of Paladin's Strategic Advisory Group,
is a Professor of Management at Yale University
, a member of the Council on Foreign Relations
and serves on the board of advisors for "D" Division
of Los Alamos Laboratories and on the Chief
of Naval Operations Executive Panel
ABOUT WESTPARK CAPITAL, INC.
WestPark Capital, Inc. is a full service
investment banking and securities brokerage
firm that serves the needs of both private
and public companies worldwide, as well
as individual and institutional investors. WestPark
is committed to forging lasting partnerships
with emerging growth companies and the
investors who back them. WestPark's
approach is to provide customized financial
solutions for virtually any need. A
complete range of investment banking and
brokerage services is available to corporate
and individual clients. WestPark's corporate
finance professionals have the depth of
experience and resources to create integrated
financing solutions for both private and
public marketplaces. Additionally,
WestPark offers an exceptional array of
private client services through its dedicated
group of financial consultants. WestPark
Capital understands the importance of strong
relationships in today's dynamic business
environment and welcomes the opportunity
to leverage this power into success for
its customers.
For more information visit www.wpcapital.com .
For further information,
please contact:
Richard Rappaport
Anthony Pintsopoulos
WestPark Capital, Inc. (310) 843-9300
1900 Avenue of the Stars, Suite 310
Los Angeles, CA 90067
http://www.wpcapital.com |
International
Locations*
Beijing, China
Shanghai, China
Hong
Kong
Taipei, Taiwan
Canada |